Skip to main content
. 2022 Jun 7;20:263. doi: 10.1186/s12951-022-01457-y

Table 2.

In vivo NO production assessment

Group Name Treatment*
1 Control Saline
2 LPS LPS
3 PCM-MSN PCM-MSN + LPS
4 MSN@LA MSN@LA + LPS
5 PCM-MSN@LA PCM-MSN@LA + LPS
6 PCM-MSN@LA + LIFU PCM-MSN@LA + LPS, with LIFU irradiation

*PCM-MSN, MSN@LA and PCM-MSN@LA were all administrated at a dosage of 1 mg kg−1 for 2 min before LPS injection